Gary Middleton
1 - 10 out of 76Page size: 10
Publications
- 2020
- Published
- Published
Utility of COVID-19 screening in cancer patients
14 Sep 2020, In: Cancer Cell. 38, 3, p. 306-307 2 p.Research output: Contribution to journal › Letter › peer-review
- E-pub ahead of print
Publisher Correction: The National Lung Matrix Trial of personalized therapy in lung cancer
Gary Middleton, Amanda Farley & 7 others, , 5 Sep 2020, In: Nature.Research output: Contribution to journal › Article
- Published
Immune checkpoint blockade: releasing the breaks or a protective barrier to COVID-19 severe acute respiratory syndrome?
Oliver Pickles, Lennard Lee & Gary Middleton, Sep 2020, In: British Journal of Cancer. 123, 5, p. 691-693 3 p.Research output: Contribution to journal › Article › peer-review
- Published
Pembrolizumab in patients with non-small-cell lung cancer of performance status 2 (PePS2): a single arm, phase 2 trial
Gary Middleton, Kristian Brock & Lucinda Billingham, Sep 2020, In: The Lancet Respiratory Medicine. 8, 9, p. 895-904 10 p.Research output: Contribution to journal › Article › peer-review
- Published
COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study
24 Aug 2020, In: The Lancet Oncology.Research output: Contribution to journal › Article › peer-review
- Published
Correction to: Use of an Integrated Pan-Cancer Oncology Enrichment Next-Generation Sequencing Assay to Measure Tumour Mutational Burden and Detect Clinically Actionable Variants
Valerie Somani, Gary Middleton & Andrew Beggs, Aug 2020, In: Molecular Diagnosis and Therapy. 24, 4, p. 505Research output: Contribution to journal › Article › peer-review
- Published
The National Lung Matrix Trial of personalized therapy in lung cancer
Gary Middleton, Amanda Farley & 7 others, , 15 Jul 2020, In: Nature. 583, 7818, p. 807-812 6 p.Research output: Contribution to journal › Article › peer-review
- Published
COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study
26 Jun 2020, In: The Lancet. 395, 10241, p. 1919-1926 8 p.Research output: Contribution to journal › Article › peer-review
- Published
BRAF-mutant transcriptional subtypes predict outcome of combined BRAF, MEK, and EGFR blockade with dabrafenib, trametinib, and panitumumab in patients with colorectal cancer
Gary Middleton & 2 others, , Jun 2020, In: Clinical Cancer Research. 26, 11, p. 2466-2476 11 p.Research output: Contribution to journal › Article › peer-review